SEFULNESS OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS DURING CAESAREAN DELIVERY IN IBADA

Not Applicable

• Conditions: Circulatory System; Pregnancy and Childbirth; HAEMORRHAGE

• Registration Number: PACTR201804002955302
• Lead Sponsor: niversity College Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-09
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 71

Inclusion Criteria

Pregnant women scheduled for primary elective or emergency caesarean delivery

Exclusion Criteria

1.Severe medical and surgical complications involving the heart, liver or kidney, and blood disorder.
2.Allergy to tranexamic acid.
3.Known risk factors for postpartum haemorrhage such as previous caesarean delivery, multiple pregnancy, placenta praevia, morbidly adherent placenta, previous myomectomy, co-existing uterine fibroid in pregnancy.
4.History of thrombo-embolic disorder or risk factors for thromboembolic disorder such as Sickle Cell disease.
5.Refusal to consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Amount of blood loss during caesarean delivery

Secondary Outcome Measures

Name	Time	Method
eed for additional uterotonics;Need for other surgical measures to stop bleeding ;Maternal and neonatal side effects of medications given